Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
An Israeli pharma champion sickens
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
These Israeli pharmaceutical stocks are down in the wake of Hamas attack - MarketWatch
Teva boss hits out at opioid lawsuits
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva to pay $225 million to settle cholesterol drug price-fixing charges | The Times of Israel
San Francisco reaches $58m opioid settlement with Teva, Allergan | Drugs News | Al Jazeera
With 3K-plus Teva layoffs slated in Israel and labor protests brewing, top exec steps aside | Fierce Pharma
Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Israel targets Teva over MS drug royalties
Teva Pharmaceuticals - Wikipedia
Teva Lifts Outlook With Drug Production Mostly Unaffected by War - Bloomberg
